HealthEquity, Inc. $HQY Shares Acquired by Radnor Capital Management LLC

Radnor Capital Management LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 130.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,366 shares of the company’s stock after purchasing an additional 8,126 shares during the quarter. Radnor Capital Management LLC’s holdings in HealthEquity were worth $1,268,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Capricorn Fund Managers Ltd acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $6,926,000. 12th Street Asset Management Company LLC lifted its position in shares of HealthEquity by 114.4% during the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock valued at $25,784,000 after buying an additional 145,151 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in shares of HealthEquity by 45.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock valued at $14,741,000 after buying an additional 48,621 shares in the last quarter. Bessemer Group Inc. lifted its position in shares of HealthEquity by 21.3% during the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock valued at $33,108,000 after buying an additional 61,317 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of HealthEquity by 11.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock valued at $114,205,000 after buying an additional 124,283 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Up 1.1%

Shares of HQY opened at $83.04 on Tuesday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $116.65. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. The firm’s fifty day moving average is $81.85 and its two-hundred day moving average is $87.13. The stock has a market cap of $6.96 billion, a PE ratio of 33.76, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The company had revenue of $334.59 million for the quarter, compared to analysts’ expectations of $332.48 million. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. Research analysts forecast that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent analyst reports. BTIG Research decreased their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research report on Tuesday, February 17th. Barrington Research decreased their target price on HealthEquity from $125.00 to $110.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 18th. Royal Bank Of Canada decreased their target price on HealthEquity from $110.00 to $100.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 18th. Raymond James Financial set a $100.00 target price on HealthEquity in a research report on Tuesday, February 17th. Finally, Barclays decreased their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $111.79.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.